Papamichael, K., Juncadella, A., Wong, D., Rakowsky, S., Sattler, L. A., Campbell, J. P., . . . Cheifetz, A. S. (2019). Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease. J Crohns Colitis.

Papamichael, Konstantinos, Anna Juncadella, Danny Wong, Shana Rakowsky, Lindsey A. Sattler, James P. Campbell, Byron P. Vaughn, and Adam S. Cheifetz. "Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease." J Crohns Colitis 2019.

Papamichael, Konstantinos, et al. "Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease." J Crohns Colitis 2019.